ANNALS OF THORACIC SURGERY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial，一周后送审都没有直接给拒了，说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了，人家根本看不上，连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久，这是要拒稿的前兆吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心胸外科 经验分享：一审2个月（大修），二审2个月（小修），返修后半个月接收，之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向：胸腔外科;胸外科 经验分享：请问前辈们，这本杂志投出去一般with editor多久送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0 经验分享：这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一，严格。二，编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿，一审1个月3天，四个审稿人给了及其详细的意见，小修。11月30日修回，期间由于圣诞及新年耽误了一段时间，今年1月4日接受。语言要求确实较高，润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢？156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肺癌 经验分享：第一次投稿就接收了，分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说，胸外科的顶刊，很注重创新性，审稿周期较长，一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：胸心血管外科领域的老牌期刊，认可度很高，仅次于JTCVS。今年真的非常幸运，上半年同期投了2篇original article，均为一审3个月后大修，第一次修回后再次审稿1个月，再次修回后继续审稿1个月。之后收到接受邮件。算了下时间，每一篇差不多历时7个月左右。总的来说，耗时还是有些长，着急毕业的同学避开好一些，以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]

2022-04-10 ms9000000799627797

投了篇少见病例的case serial，一周后送审都没有直接给拒了，说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了，人家根本看不上，连审都不送。

76 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial，一周后送审都没有直接给拒了，说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了，人家根本看不上，连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久，这是要拒稿的前兆吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心胸外科 经验分享：一审2个月（大修），二审2个月（小修），返修后半个月接收，之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向：胸腔外科;胸外科 经验分享：请问前辈们，这本杂志投出去一般with editor多久送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0 经验分享：这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一，严格。二，编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿，一审1个月3天，四个审稿人给了及其详细的意见，小修。11月30日修回，期间由于圣诞及新年耽误了一段时间，今年1月4日接受。语言要求确实较高，润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢？156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肺癌 经验分享：第一次投稿就接收了，分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说，胸外科的顶刊，很注重创新性，审稿周期较长，一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：胸心血管外科领域的老牌期刊，认可度很高，仅次于JTCVS。今年真的非常幸运，上半年同期投了2篇original article，均为一审3个月后大修，第一次修回后再次审稿1个月，再次修回后继续审稿1个月。之后收到接受邮件。算了下时间，每一篇差不多历时7个月左右。总的来说，耗时还是有些长，着急毕业的同学避开好一些，以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]

2022-04-17 libing2013

一般Decision in Process阶段要多久，这是要拒稿的前兆吗？

78 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial，一周后送审都没有直接给拒了，说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了，人家根本看不上，连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久，这是要拒稿的前兆吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心胸外科 经验分享：一审2个月（大修），二审2个月（小修），返修后半个月接收，之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向：胸腔外科;胸外科 经验分享：请问前辈们，这本杂志投出去一般with editor多久送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0 经验分享：这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一，严格。二，编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿，一审1个月3天，四个审稿人给了及其详细的意见，小修。11月30日修回，期间由于圣诞及新年耽误了一段时间，今年1月4日接受。语言要求确实较高，润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢？156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肺癌 经验分享：第一次投稿就接收了，分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说，胸外科的顶刊，很注重创新性，审稿周期较长，一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：胸心血管外科领域的老牌期刊，认可度很高，仅次于JTCVS。今年真的非常幸运，上半年同期投了2篇original article，均为一审3个月后大修，第一次修回后再次审稿1个月，再次修回后继续审稿1个月。之后收到接受邮件。算了下时间，每一篇差不多历时7个月左右。总的来说，耗时还是有些长，着急毕业的同学避开好一些，以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]

2021-12-04 14877f0fm82暂无昵称

with editor20天了

92 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial，一周后送审都没有直接给拒了，说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了，人家根本看不上，连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久，这是要拒稿的前兆吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心胸外科 经验分享：一审2个月（大修），二审2个月（小修），返修后半个月接收，之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向：胸腔外科;胸外科 经验分享：请问前辈们，这本杂志投出去一般with editor多久送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0 经验分享：这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一，严格。二，编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿，一审1个月3天，四个审稿人给了及其详细的意见，小修。11月30日修回，期间由于圣诞及新年耽误了一段时间，今年1月4日接受。语言要求确实较高，润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢？156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肺癌 经验分享：第一次投稿就接收了，分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说，胸外科的顶刊，很注重创新性，审稿周期较长，一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：胸心血管外科领域的老牌期刊，认可度很高，仅次于JTCVS。今年真的非常幸运，上半年同期投了2篇original article，均为一审3个月后大修，第一次修回后再次审稿1个月，再次修回后继续审稿1个月。之后收到接受邮件。算了下时间，每一篇差不多历时7个月左右。总的来说，耗时还是有些长，着急毕业的同学避开好一些，以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]

2021-11-12 wangzzzzzzz

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：心胸外科
经验分享：一审2个月（大修），二审2个月（小修），返修后半个月接收，之后等待见刊时间会比较漫长。注重创新性。

92 0

[GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial，一周后送审都没有直接给拒了，说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了，人家根本看不上，连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久，这是要拒稿的前兆吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心胸外科 经验分享：一审2个月（大修），二审2个月（小修），返修后半个月接收，之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向：胸腔外科;胸外科 经验分享：请问前辈们，这本杂志投出去一般with editor多久送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0 经验分享：这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一，严格。二，编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿，一审1个月3天，四个审稿人给了及其详细的意见，小修。11月30日修回，期间由于圣诞及新年耽误了一段时间，今年1月4日接受。语言要求确实较高，润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢？156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肺癌 经验分享：第一次投稿就接收了，分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说，胸外科的顶刊，很注重创新性，审稿周期较长，一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：胸心血管外科领域的老牌期刊，认可度很高，仅次于JTCVS。今年真的非常幸运，上半年同期投了2篇original article，均为一审3个月后大修，第一次修回后再次审稿1个月，再次修回后继续审稿1个月。之后收到接受邮件。算了下时间，每一篇差不多历时7个月左右。总的来说，耗时还是有些长，着急毕业的同学避开好一些，以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]

2021-10-03 ms7000000117561646

偏重的研究方向：胸腔外科;胸外科
经验分享：请问前辈们，这本杂志投出去一般with editor多久送审？

102 0

[GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial，一周后送审都没有直接给拒了，说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了，人家根本看不上，连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久，这是要拒稿的前兆吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心胸外科 经验分享：一审2个月（大修），二审2个月（小修），返修后半个月接收，之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向：胸腔外科;胸外科 经验分享：请问前辈们，这本杂志投出去一般with editor多久送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0 经验分享：这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一，严格。二，编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿，一审1个月3天，四个审稿人给了及其详细的意见，小修。11月30日修回，期间由于圣诞及新年耽误了一段时间，今年1月4日接受。语言要求确实较高，润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢？156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肺癌 经验分享：第一次投稿就接收了，分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说，胸外科的顶刊，很注重创新性，审稿周期较长，一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：胸心血管外科领域的老牌期刊，认可度很高，仅次于JTCVS。今年真的非常幸运，上半年同期投了2篇original article，均为一审3个月后大修，第一次修回后再次审稿1个月，再次修回后继续审稿1个月。之后收到接受邮件。算了下时间，每一篇差不多历时7个月左右。总的来说，耗时还是有些长，着急毕业的同学避开好一些，以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]

2018-01-25 我是医学神

需要提供原始数据嘛

323 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial，一周后送审都没有直接给拒了，说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了，人家根本看不上，连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久，这是要拒稿的前兆吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心胸外科 经验分享：一审2个月（大修），二审2个月（小修），返修后半个月接收，之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向：胸腔外科;胸外科 经验分享：请问前辈们，这本杂志投出去一般with editor多久送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0 经验分享：这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一，严格。二，编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿，一审1个月3天，四个审稿人给了及其详细的意见，小修。11月30日修回，期间由于圣诞及新年耽误了一段时间，今年1月4日接受。语言要求确实较高，润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢？156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肺癌 经验分享：第一次投稿就接收了，分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说，胸外科的顶刊，很注重创新性，审稿周期较长，一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：胸心血管外科领域的老牌期刊，认可度很高，仅次于JTCVS。今年真的非常幸运，上半年同期投了2篇original article，均为一审3个月后大修，第一次修回后再次审稿1个月，再次修回后继续审稿1个月。之后收到接受邮件。算了下时间，每一篇差不多历时7个月左右。总的来说，耗时还是有些长，着急毕业的同学避开好一些，以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]

2016-02-01 Rivers Lee

审稿速度:3.0
经验分享：这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一，严格。二，编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿，一审1个月3天，四个审稿人给了及其详细的意见，小修。11月30日修回，期间由于圣诞及新年耽误了一段时间，今年1月4日接受。语言要求确实较高，润色很有必要的。

457 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial，一周后送审都没有直接给拒了，说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了，人家根本看不上，连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久，这是要拒稿的前兆吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心胸外科 经验分享：一审2个月（大修），二审2个月（小修），返修后半个月接收，之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向：胸腔外科;胸外科 经验分享：请问前辈们，这本杂志投出去一般with editor多久送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0 经验分享：这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一，严格。二，编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿，一审1个月3天，四个审稿人给了及其详细的意见，小修。11月30日修回，期间由于圣诞及新年耽误了一段时间，今年1月4日接受。语言要求确实较高，润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢？156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肺癌 经验分享：第一次投稿就接收了，分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说，胸外科的顶刊，很注重创新性，审稿周期较长，一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：胸心血管外科领域的老牌期刊，认可度很高，仅次于JTCVS。今年真的非常幸运，上半年同期投了2篇original article，均为一审3个月后大修，第一次修回后再次审稿1个月，再次修回后继续审稿1个月。之后收到接受邮件。算了下时间，每一篇差不多历时7个月左右。总的来说，耗时还是有些长，着急毕业的同学避开好一些，以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]

2019-07-05 12400f3bm31暂无昵称

小修后多久接收的呢？156qvWc1738(暂无昵称) 2019-01-03 发表::
我最近也投了一篇case，20多天with editor后直接decision，现在在小修156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表:
我最近也投了一篇case，20多天with editor后直接decision，现在在小修

156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修

239 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial，一周后送审都没有直接给拒了，说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了，人家根本看不上，连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久，这是要拒稿的前兆吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心胸外科 经验分享：一审2个月（大修），二审2个月（小修），返修后半个月接收，之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向：胸腔外科;胸外科 经验分享：请问前辈们，这本杂志投出去一般with editor多久送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0 经验分享：这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一，严格。二，编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿，一审1个月3天，四个审稿人给了及其详细的意见，小修。11月30日修回，期间由于圣诞及新年耽误了一段时间，今年1月4日接受。语言要求确实较高，润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢？156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肺癌 经验分享：第一次投稿就接收了，分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说，胸外科的顶刊，很注重创新性，审稿周期较长，一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：胸心血管外科领域的老牌期刊，认可度很高，仅次于JTCVS。今年真的非常幸运，上半年同期投了2篇original article，均为一审3个月后大修，第一次修回后再次审稿1个月，再次修回后继续审稿1个月。之后收到接受邮件。算了下时间，每一篇差不多历时7个月左右。总的来说，耗时还是有些长，着急毕业的同学避开好一些，以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]

2021-06-15 14845858m75(暂无昵称)

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：肺癌
经验分享：第一次投稿就接收了，分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说，胸外科的顶刊，很注重创新性，审稿周期较长，一般需半年左右

98 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1210048, encodeId=5cdd121004866, content=投了篇少见病例的case serial，一周后送审都没有直接给拒了，说是因为样本量太少还没有对照组……感觉类似类型的文章就不要太指望了，人家根本看不上，连审都不送。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbfd5621633, createdName=ms9000000799627797, createdTime=Sun Apr 10 16:08:53 CST 2022, time=2022-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212008, encodeId=3fca121200811, content=一般Decision in Process阶段要多久，这是要拒稿的前兆吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17495529301, createdName=libing2013, createdTime=Sun Apr 17 22:21:28 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076853, encodeId=37d310e6853ba, content=with editor20天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7a2c5305840, createdName=14877f0fm82暂无昵称, createdTime=Sat Dec 04 15:14:10 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069675, encodeId=eeca10696e50a, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：心胸外科 经验分享：一审2个月（大修），二审2个月（小修），返修后半个月接收，之后等待见刊时间会比较漫长。注重创新性。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJaicGoPL4gRLibjrGJ6NViacZ9ZhGgUVTU3cClwuaUqUjB2BBSHqiaMknDicckus13ZHgf1t8XBqS5gAw/132, createdBy=cfc11961463, createdName=wangzzzzzzz, createdTime=Fri Nov 12 16:06:55 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057118, encodeId=2cde105e1188a, content=偏重的研究方向：胸腔外科;胸外科 经验分享：请问前辈们，这本杂志投出去一般with editor多久送审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e68c5479077, createdName=ms7000000117561646, createdTime=Sun Oct 03 14:59:39 CST 2021, time=2021-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552010, encodeId=94ff55201025, content=需要提供原始数据嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=323, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLAKRcycZj5TgibHLqoLic8zCf69Ffa4DofbTqhibfZMptfLGFU0iawDEYasjWDNcGKcvfbfmHVjTbkkQ/132, createdBy=46c52015377, createdName=我是医学神, createdTime=Thu Jan 25 20:55:00 CST 2018, time=2018-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518964, encodeId=ef6751896493, content=审稿速度:3.0 经验分享：这个期刊是胸外科专科领域的顶级三大期刊之一。我个人的投稿经历就是感觉有两点。一，严格。二，编辑非常友好。我一点都没有感觉到前面站友说到的歧视的问题。去年10月14日投稿，一审1个月3天，四个审稿人给了及其详细的意见，小修。11月30日修回，期间由于圣诞及新年耽误了一段时间，今年1月4日接受。语言要求确实较高，润色很有必要的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=457, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=295f1662192, createdName=Rivers Lee, createdTime=Mon Feb 01 21:30:00 CST 2016, time=2016-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573354, encodeId=ac065e3354a6, content=小修后多久接收的呢？156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修156qvWc1738(暂无昵称) 2019-01-03 00:00:00 发表: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, beContent=156qvWc1738(暂无昵称) 2019-01-03 发表:: 我最近也投了一篇case，20多天with editor后直接decision，现在在小修, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b622454706, createdName=12400f3bm31暂无昵称, createdTime=Fri Jul 05 00:00:00 CST 2019, time=2019-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973774, encodeId=d9de9e3774d5, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肺癌 经验分享：第一次投稿就接收了，分享一下自己的投稿过程:26/9投稿 4/10 With Editor 10/10 Under Review 28/12 Decision in process 31/12/2020 Revised 8/1/2021 Under Review 22/4 Accepted 5/5 Online 总体来说，胸外科的顶刊，很注重创新性，审稿周期较长，一般需半年左右, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=70b95282001, createdName=14845858m75(暂无昵称), createdTime=Tue Jun 15 17:00:43 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561412, encodeId=7eec561412eb, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：胸心血管外科领域的老牌期刊，认可度很高，仅次于JTCVS。今年真的非常幸运，上半年同期投了2篇original article，均为一审3个月后大修，第一次修回后再次审稿1个月，再次修回后继续审稿1个月。之后收到接受邮件。算了下时间，每一篇差不多历时7个月左右。总的来说，耗时还是有些长，着急毕业的同学避开好一些，以免发生意外。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=354, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b3033950, createdName=tuodi1986xjtu, createdTime=Mon Sep 24 23:20:00 CST 2018, time=2018-09-24, status=1, ipAttribution=)]

2018-09-24 tuodi1986xjtu

审稿速度:3.0 | 投稿命中率:50.0
经验分享：胸心血管外科领域的老牌期刊，认可度很高，仅次于JTCVS。今年真的非常幸运，上半年同期投了2篇original article，均为一审3个月后大修，第一次修回后再次审稿1个月，再次修回后继续审稿1个月。之后收到接受邮件。算了下时间，每一篇差不多历时7个月左右。总的来说，耗时还是有些长，着急毕业的同学避开好一些，以免发生意外。

354 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务